OrganoClick AB (publ)

OM:ORGC Stock Report

Market Cap: SEK 175.6m

OrganoClick Future Growth

Future criteria checks 4/6

OrganoClick is forecast to grow earnings and revenue by 70.9% and 7.4% per annum respectively. EPS is expected to grow by 91% per annum. Return on equity is forecast to be -3.1% in 3 years.

Key information

70.9%

Earnings growth rate

90.97%

EPS growth rate

Chemicals earnings growth13.2%
Revenue growth rate7.4%
Future return on equity-3.15%
Analyst coverage

Low

Last updated09 Jul 2025

Recent future growth updates

kr2.50: That's What Analysts Think OrganoClick AB (publ) (STO:ORGC) Is Worth After Its Latest Results

May 09
kr2.50: That's What Analysts Think OrganoClick AB (publ) (STO:ORGC) Is Worth After Its Latest Results

Recent updates

OrganoClick (STO:ORGC) Is Making Moderate Use Of Debt

Jul 16
OrganoClick (STO:ORGC) Is Making Moderate Use Of Debt

It's Probably Less Likely That OrganoClick AB (publ)'s (STO:ORGC) CEO Will See A Huge Pay Rise This Year

May 14
It's Probably Less Likely That OrganoClick AB (publ)'s (STO:ORGC) CEO Will See A Huge Pay Rise This Year

kr2.50: That's What Analysts Think OrganoClick AB (publ) (STO:ORGC) Is Worth After Its Latest Results

May 09
kr2.50: That's What Analysts Think OrganoClick AB (publ) (STO:ORGC) Is Worth After Its Latest Results

Cautious Investors Not Rewarding OrganoClick AB (publ)'s (STO:ORGC) Performance Completely

May 05
Cautious Investors Not Rewarding OrganoClick AB (publ)'s (STO:ORGC) Performance Completely

Would OrganoClick (STO:ORGC) Be Better Off With Less Debt?

Feb 14
Would OrganoClick (STO:ORGC) Be Better Off With Less Debt?

A Piece Of The Puzzle Missing From OrganoClick AB (publ)'s (STO:ORGC) 26% Share Price Climb

Jun 19
A Piece Of The Puzzle Missing From OrganoClick AB (publ)'s (STO:ORGC) 26% Share Price Climb

Shareholders May Find It Hard To Justify Increasing OrganoClick AB (publ)'s (STO:ORGC) CEO Compensation For Now

May 09
Shareholders May Find It Hard To Justify Increasing OrganoClick AB (publ)'s (STO:ORGC) CEO Compensation For Now

Earnings Release: Here's Why Analysts Cut Their OrganoClick AB (publ) (STO:ORGC) Price Target To kr3.00

May 03
Earnings Release: Here's Why Analysts Cut Their OrganoClick AB (publ) (STO:ORGC) Price Target To kr3.00

Sentiment Still Eluding OrganoClick AB (publ) (STO:ORGC)

Mar 25
Sentiment Still Eluding OrganoClick AB (publ) (STO:ORGC)

Earnings Update: OrganoClick AB (publ) (STO:ORGC) Just Reported And Analysts Are Trimming Their Forecasts

Feb 18
Earnings Update: OrganoClick AB (publ) (STO:ORGC) Just Reported And Analysts Are Trimming Their Forecasts

OrganoClick (STO:ORGC) Seems To Use Debt Quite Sensibly

Jan 09
OrganoClick (STO:ORGC) Seems To Use Debt Quite Sensibly

Is OrganoClick AB (publ) (STO:ORGC) Potentially Undervalued?

May 11
Is OrganoClick AB (publ) (STO:ORGC) Potentially Undervalued?

There's No Escaping OrganoClick AB (publ)'s (STO:ORGC) Muted Revenues Despite A 33% Share Price Rise

Apr 18
There's No Escaping OrganoClick AB (publ)'s (STO:ORGC) Muted Revenues Despite A 33% Share Price Rise

Here's Why OrganoClick (STO:ORGC) Can Afford Some Debt

Jan 25
Here's Why OrganoClick (STO:ORGC) Can Afford Some Debt

Does OrganoClick (STO:ORGC) Have A Healthy Balance Sheet?

Sep 21
Does OrganoClick (STO:ORGC) Have A Healthy Balance Sheet?

Earnings and Revenue Growth Forecasts

OM:ORGC - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2027170315291
12/31/2026152-42121
12/31/2025130-15-20-91
6/30/2025116-23-110N/A
3/31/2025124-19-84N/A
12/31/2024127-18-64N/A
9/30/2024134-18-46N/A
6/30/2024138-17-18N/A
3/31/2024141-17-35N/A
12/31/2023146-16-81N/A
9/30/2023140-28-13-6N/A
6/30/2023128-33-14-4N/A
3/31/2023126-40-31-20N/A
12/31/2022115-44-35-21N/A
9/30/2022111-36-48-33N/A
6/30/2022112-35-51-37N/A
3/31/2022113-32-51-36N/A
12/31/2021110-33-52-38N/A
9/30/2021110-31-37-21N/A
6/30/2021108-29-40-17N/A
3/31/2021104-24-31-9N/A
12/31/202096-24-145N/A
9/30/202093-23-27-9N/A
6/30/202089-23-19-11N/A
3/31/202086-23-21-12N/A
12/31/201985-20-18-11N/A
9/30/201984-18-11-5N/A
6/30/201984-18-12-7N/A
3/31/201982-18N/A-8N/A
12/31/201878-20N/A-19N/A
9/30/201878-23N/A-21N/A
6/30/201878-24N/A-31N/A
3/31/201875-26N/A-29N/A
12/31/201775-28N/A-23N/A
9/30/201769-26N/A-19N/A
6/30/201762-26N/A-17N/A
3/31/201751-28N/A-18N/A
12/31/201640-29N/A-16N/A
9/30/201638-28N/A-19N/A
6/30/201637-25N/A-13N/A
3/31/201633-22N/A-18N/A
12/31/201532-20N/A-24N/A
9/30/201530-17N/A-20N/A
6/30/201527-16N/A-17N/A
3/31/201524-16N/A-16N/A
12/31/201421-16N/A-17N/A
9/30/201420-15N/A-30N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ORGC is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.5%).

Earnings vs Market: ORGC is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: ORGC is expected to become profitable in the next 3 years.

Revenue vs Market: ORGC's revenue (7.4% per year) is forecast to grow faster than the Swedish market (5.5% per year).

High Growth Revenue: ORGC's revenue (7.4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: ORGC is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/20 03:12
End of Day Share Price 2025/07/18 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

OrganoClick AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullABG Sundal Collier
Johan BrownABG Sundal Collier Sponsored
null nullABG Sundal Collier Sponsored